Limits...
The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus

Determinants of Risk of Infection.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f006: Determinants of Risk of Infection.

Mentions: In the model, sexually active and IDU populations are exposed to infection each year with the probability of infection associated with several epidemiological and behavioral factors. (Figure A2) HIV prevalence of sex partners is assumed to be the same as the HIV prevalence of the opposite sex in the same risk group.


The Potential Impact of Preventive HIV Vaccines in China: Results and Benefits of a Multi-Province Modeling Collaboration.

Harmon T, Guo W, Stover J, Wu Z, Kaufman J, Schneider K, Liu L, Feng L, Schwartländer B - Vaccines (Basel) (2015)

Determinants of Risk of Infection.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494240&req=5

vaccines-03-00001-f006: Determinants of Risk of Infection.
Mentions: In the model, sexually active and IDU populations are exposed to infection each year with the probability of infection associated with several epidemiological and behavioral factors. (Figure A2) HIV prevalence of sex partners is assumed to be the same as the HIV prevalence of the opposite sex in the same risk group.

Bottom Line: China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response.This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection.A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

View Article: PubMed Central - PubMed

Affiliation: International AIDS Vaccine Initiative, 125 Broad St., 9th Floor, New York, NY 10004, USA. tharmon@iavi.org.

ABSTRACT
China's commitment to implementing established and emerging HIV/AIDS prevention and control strategies has led to substantial gains in terms of access to antiretroviral treatment and prevention services, but the evolving and multifaceted HIV/AIDS epidemic in China highlights the challenges of maintaining that response. This study presents modeling results exploring the potential impact of HIV vaccines in the Chinese context at varying efficacy and coverage rates, while further exploring the potential implications of vaccination programs aimed at reaching populations at highest risk of HIV infection. A preventive HIV vaccine would add a powerful tool to China's response, even if not 100% efficacious or available to the full population.

No MeSH data available.


Related in: MedlinePlus